There has been a report that the presence of mutations in PIK3CA, KRAS, or BRAF in CRC showed worse patient outcome [7], and among patients who undergo a curative resection of CRC, PIK3CA mutation is associated with shorter cancer-specific survival [8]. The gene discussed is KRAS; the disease is colorectal carcinoma.